(Q43456447)

English

Enhanced CD8+ T cell immune response against a V3 loop multi-epitope polypeptide (TAB13) of HIV-1 Env after priming with purified fusion protein and booster with modified vaccinia virus Ankara (MVA-TAB) recombinant: a comparison of humoral and cellu

scientific article published in December 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Enhanced CD8+ T cell immune response against a V3 loop multi-epitope polypeptide (TAB13) of HIV-1 Env after priming with purified fusion protein and booster with modified vaccinia virus Ankara (MVA-TAB) recombinant: a comparison of humoral and cellu (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

object named as

vaccinia virus

1 reference

based on heuristic

inferred from title

Carmen E Gómez

1

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Mariano Esteban

6

object named as

Esteban M

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

author name string

Rodríguez D

2

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Rodríguez JR

3

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Abaitua F

4

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Duarte C

5

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

language of work or name

0 references

publication date

1 December 2001

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

5-6

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

961-971

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Immune responses in HIV-exposed seronegatives: have they repelled the virus?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of human immunodeficiency virus type 1 (HIV-1)-specific cytolytic T lymphocyte responses in seronegative adults by a nonreplicating, host-range-restricted canarypox vector (ALVAC) carrying the HIV-1MN env gene

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Memory cytotoxic T lymphocyte responses in human immunodeficiency virus type 1 (HIV-1)-negative volunteers immunized with a recombinant canarypox expressing gp 160 of HIV-1 and boosted with a recombinant gp160.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytotoxic T cell and neutralizing antibody responses to human immunodeficiency virus type 1 envelope with a combination vaccine regimen. AIDS Vaccine Evaluation Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Alteration of HIV-1 infectivity and neutralization by a single amino acid replacement in the V3 loop domain

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A V3 loop haptenic peptide sequence, when tandemly repeated, enhances immunogenicity by facilitating helper T-cell responses to a covalently linked carrier protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A single amino acid interchange yields reciprocal CTL specificities for HIV-1 gp160

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Structural requirements for class I MHC molecule-mediated antigen presentation and cytotoxic T cell recognition of an immunodominant determinant of the human immunodeficiency virus envelope protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Envelope protein and p18(IIIB) peptide recognized by cytotoxic T lymphocytes from humans immunized with human immunodeficiency virus envelope

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytotoxic T lymphocytes specific for HIV-1 gp160 antigen and synthetic P18IIIB peptide in an HLA-A11-immunized individual

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular analysis of presentation by HLA-A2.1 of a promiscuously binding V3 loop peptide from the HIV-envelope protein to human cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

An immunodominant class I-restricted cytotoxic T lymphocyte determinant of human immunodeficiency virus type 1 induces CD4 class II-restricted help for itself

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Broadly reactive antibodies against a gp120 V3 loop multi-epitope polypeptide neutralize different isolates of human immunodeficiency virus type 1 (HIV-1).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The V3 loop based multi-epitope polypeptide TAB9 adjuvated with montanide ISA720 is highly immunogenic in nonhuman primates and induces neutralizing antibodies against five HIV-1 isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccinia virus: a tool for research and vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Applications of pox virus vectors to vaccination: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A human immunodeficiency virus type 1 Env-granulocyte-macrophage colony-stimulating factor fusion protein enhances the cellular immune response to Env in a vaccinia virus-based vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Infectious poxvirus vectors have capacity for at least 25 000 base pairs of foreign DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Mucosal and systemic immune responses induced after oral delivery of vaccinia virus recombinants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of CD8+ T cells using heterologous prime-boost immunisation strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant viruses expressing a human malaria antigen can elicit potentially protective immune CD8+ responses in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Isolation and characterization of attenuated mutants of vaccinia virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiepitope polypeptide of the HIV-1 envelope induces neutralizing monoclonal antibodies against V3 loop

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantification of antigen specific CD8+ T cells using an ELISPOT assay

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

NYVAC: a highly attenuated strain of vaccinia virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of a recombinant fowl pox-based Newcastle disease virus vaccine candidate against velogenic and respiratory challenge.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

New prospects for the development of a vaccine against human immunodeficiency virus type 1. An overview

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Studies on poxvirus infections in irradiated animals

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Biology of attenuated modified vaccinia virus Ankara recombinant vector in mice: virus fate and activation of B- and T-cell immune responses in comparison with the Western Reserve strain and advantages as a vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic vaccination strategies for enhanced cellular, humoral and mucosal immunity.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A striking property of recombinant poxviruses: efficient inducers of in vivo expansion of primed CD8(+) T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Early suppression of SIV replication by CD8+ nef-specific cytotoxic T cells in vaccinated macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Viral mechanisms of immune evasion

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A prime-boost approach to HIV preventive vaccine using a recombinant canarypox virus expressing glycoprotein 160 (MN) followed by a recombinant glycoprotein 160 (MN/LAI). The AGIS Group, and l'Agence Nationale de Recherche sur le SIDA.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Humoral immune response elicited by highly attenuated variants of vaccinia virus and by an attenuated recombinant expressing HIV-1 envelope protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Highly efficient induction of protective immunity by a vaccinia virus vector defective in late gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0264-410X(01)00389-9

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43456447&oldid=2115368497"